Loading...
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens
Peritoneal metastasis (PM) have an incidence of 10–20% in patients with gastric cancer (GC), and even up to 40% in patients with UICC Stage III GC. Due to the aggressive characteristic of adenocarcinoma of the stomach, GC is the third leading cause of cancer deaths worldwide. For GC with PM, the tre...
Saved in:
| Published in: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100714/ https://ncbi.nlm.nih.gov/pubmed/33968424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-2020-04 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|